![Matteo Levisetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matteo Levisetti
Keine laufenden Positionen mehr
Vermögen: 9 720 $ am 30.06.2026
Profil
Matteo Levisetti worked as Executive Director-Clinical Development at Mirati Therapeutics, Inc. from 2016 to 2017.
Served as Chief Medical Officer at Dauntless Pharmaceuticals, Inc. from 2017 to 2018.
Held the position of Chief Medical Officer at DNAtrix, Inc. from 2019 to 2021.
Worked as Chief Medical Officer at Cue Biopharma, Inc. from 2023 to 2025.
Held the role of Global Head & VP-Translational Medicine at Roche Pharmaceuticals, Inc. Worked as Assistant Professor at Washington University School of Medicine.
Education includes a doctorate degree from Pritzker School of Medicine conferred in 1996.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,01 % | 05.05.2026 | 308 ( 0,01 % ) | 9 720 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Matteo Levisetti
| Unternehmen | Position | Ende |
|---|---|---|
| CUE BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.11.2025 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2018 |
| MIRATI THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Matteo Levisetti
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Retail Trade |
Wählen Sie MarketScreener 
